Koenig Sheldon L., President and CEO, Director at Esperion Therapeutics, Inc., sold $169K of ESPR
This page documents an SEC Form 4 insider trading disclosure for $ESPR securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.
Transaction Details
| Insider | Koenig Sheldon L. |
|---|---|
| Title | President and CEO, Director |
| Company | Esperion Therapeutics, Inc. |
| Ticker | ESPR |
| Transaction Type | Sale |
| Transaction Date | 2026-06-17 |
| Shares Traded | 53,588 |
| Price Per Share | $3.155 |
| Total Value | $169K |
| Filed Date | 2026-06-18 |
| Accession Number | 0001628280-26-044266 |
Ownership Context
| Shares Owned After Transaction | 2,119,111 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001628280-26-044266
Other Insider Trades — ESPR
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Hoffman Robert E. | Director | traded | — | 2026-07-13 |
| Looker Benjamin | Chief Legal Officer | traded | — | 2026-07-13 |
| Shepard Jay | Director | traded | — | 2026-07-13 |
| Hoffman Robert E. | Director | traded | — | 2026-07-13 |
| Hoffman Robert E. | Director | traded | — | 2026-07-13 |
| Harlow John B. Jr. | Chief Commercial Officer | traded | — | 2026-07-13 |
| Shepard Jay | Director | traded | — | 2026-07-13 |
| Shepard Jay | Director | traded | — | 2026-07-13 |
| Shepard Jay | Director | traded | — | 2026-07-13 |
| Looker Benjamin | Chief Legal Officer | traded | — | 2026-07-13 |
Other Trades by Koenig Sheldon L.
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | traded | — | 2026-07-13 |
| ESPR | Esperion Therapeutics, Inc. | traded | — | 2026-07-13 |
| ESPR | Esperion Therapeutics, Inc. | traded | — | 2026-07-13 |
| ESPR | Esperion Therapeutics, Inc. | traded | — | 2026-07-13 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ESPR — Esperion Therapeutics, Inc. →
Whisper Score — ESPR
Track ESPR insider activity in real time on The Wire →
Get alerts when Koenig Sheldon L. files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: August 12, 2026 at 07:15 UTC